Gilead names remdesivir price
The treatment will cost $3,120 for a five-day treatment course for a patient with private insurance in the U.S.
The treatment will cost $3,120 for a five-day treatment course for a patient with private insurance in the U.S.
Marketers of cancer drugs spent far more than marketers of drugs for other conditions.
While advertising in medical journals remained basically flat, the biggest players increased their volume of ad pages.
A combination of profound skepticism of the industry and generous funding for health communications is a perfect storm. Is there a way through?
Belle Frank is chief strategy officer, global health practice at VMLY&R.
Experts predict the controversial tactic will be deployed far more widely this year, significantly impacting manufacturers — and, whether or not they realize it yet, patients.
Breakthrough drugs will eventually be more affordable, but a misplaced focus on their cost may prevent them from being discovered at all.
The group’s lobbying spend also doubled in 2017 as the Trump administration bore down on drug prices.
A central component of the Epidiolex marketing strategy involves highlighting the drug’s efficacy and safety profile, not its precedent-setting CBD component.
The war on cancer took a big turn with the birth of checkpoint inhibitors. Laura Entis explores their scientific and commercial impact, the unanswered questions, and what’s next for this enormously successful group of immunotherapies.
Please login or register first to view this content.